Company Filing History:
1 out of 4 
1 out of 3 
1 out of 832,843 Years Active: 2014
Title: Marco Colombatti: Innovator in Monoclonal Antibody Research
Introduction
Marco Colombatti is a notable inventor based in Sant' Anna d'Alfaedo, Italy. He has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies for cancer treatment. His innovative work focuses on targeting prostate-specific membrane antigen (PSMA), which is crucial in the diagnosis and treatment of prostate cancer.
Latest Patents
Colombatti holds a patent for an "Isolated monoclonal antibody or fragment thereof binding prostate specific membrane antigen, conjugates and uses thereof." This patent describes an isolated monoclonal antibody that binds to PSMA, preferably in its native form on the surface of tumor cells. The invention includes conjugates of the antibody with active ingredients and modified forms of the antigen-binding antibody fragment. These innovations are intended for the treatment and diagnosis of tumors or tissues associated with tumors that overexpress the PSMA antigen, particularly in prostatic neoplastic diseases.
Career Highlights
Throughout his career, Marco Colombatti has worked with prestigious institutions, including the University of Verona and the Fondazione IRCCS “Istituto Nazionale dei Tumori.” His research has significantly advanced the understanding of monoclonal antibodies and their applications in oncology. Colombatti's work has been instrumental in developing targeted therapies that improve patient outcomes in cancer treatment.
Collaborations
Colombatti has collaborated with notable colleagues such as Giulio Fracasso and Sara Cingarlini. These partnerships have fostered a collaborative environment that enhances research and innovation in the field of cancer therapeutics.
Conclusion
Marco Colombatti's contributions to monoclonal antibody research exemplify the impact of innovation in the medical field. His work continues to pave the way for advancements in cancer diagnosis and treatment, particularly for prostate cancer.